Extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) as a novel regulator of myogenic cell differentiation
- 20 July 2010
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 226 (1), 141-149
- https://doi.org/10.1002/jcp.22315
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- DHPR α1S subunit controls skeletal muscle mass and morphogenesisThe EMBO Journal, 2009
- Immunoneutralization of TGF1 Improves Skeletal Muscle Regeneration: Effects on Myoblast Differentiation and Glycosaminoglycan ContentInternational Journal of Cell Biology, 2009
- Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophyHuman Molecular Genetics, 2009
- Matrix Metalloproteinase-1 Promotes Muscle Cell Migration and DifferentiationThe American Journal of Pathology, 2009
- Basigin-Mediated Gene Expression Changes in Mouse Uterine Stromal Cells During ImplantationEndocrinology, 2009
- Basigin-2 Is a Cell Surface Receptor for Soluble Basigin LigandOnline Journal of Public Health Informatics, 2008
- Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and β1 integrin expression in vitroExperimental Cell Research, 2008
- CD147 immunoglobulin superfamily receptor function and role in pathologyExperimental and Molecular Pathology, 2007
- Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ)BMC Musculoskeletal Disorders, 2007
- Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosisBritish Journal of Cancer, 2006